The HeartMate II® is St. Jude's first-line intermediate-to-chronic left ventricular assist device. Designed to dramatically improve survival and quality of life, the HeartMate II® was developed with the goal of providing circulatory support for a broad range of advanced heart failure patients. Its small size and quiet operation make the HeartMate II® suitable for a wide range of patients, including women and those of smaller stature*. With product attributes specifically developed to minimize the risk of complications, the HeartMate II® is durable, dependable, and thromboresistant.
It offers a range of features and benefits:
- Implantation requires a less invasive surgical procedure
- Relative ease of management; completely wearable system
- Low-dose anticoagulation regimen
- Improvement of hemodynamics prior to cardiac transplantation can help optimize long-term outcomes
*The safety and effectiveness of Thoratec VADs in the paediatric population has not been established.